Introduction To investigate the diagnostic value of serum MMP-7 and SOX9 levels in patients
with biliary atresia (BA) and to further analyze their relationship with the liver fibrosis and …

Background Biliary atresia (BA) is an infantile fibro-obstructive cholestatic disease with poor
prognosis. An early diagnosis and timely Kasai portoenterostomy (KPE) improve clinical …

Biliary atresia (BA) is one of the most serious digestive system diseases, which threatens the
health of infants. Liver fibrosis is a major cause of death in children with BA. In the process of …

Background: Biliary atresia (BA) is an idiopathic progressive inflammation and fibrosclerosis
of the extra and intrahepatic bile ducts. Aim: To measure the serum levels of IL-6 and IL-8 in …

The standard‐of‐care treatment for biliary atresia (BA) is surgical restoration of bile flow by
Kasai portoenterostomy. We aimed to study serum interleukin‐(IL‐) 12p40, a natural …

Purpose Systemic and local immune environments in human biliary atresia (BA) were
analyzed. Methods Plasma concentrations of 19 inflammatory components in 16 …

The diagnosis of biliary atresia (BA) is mainly based on clinical manifestations, screening,
and related biochemistry tests. In recent years, the development of blood biomarkers and the …

Purpose Although some biomarkers of hepatic progenitor cells have been reported to be
involved in the liver fibrosis in patients with biliary atresia (BA), however, research still shows …

AIM: To evaluate liver stiffness measurement (LSM) using non-invasive transient
elastography (Fibroscan) in comparison with liver biopsy for assessment of liver fibrosis in …

BACKGROUND: Biliary atresia (BA) is an infantile disorder characterized by the obstruction
of a portion or the entirety of the extrahepatic bile ducts, leading to hepatic fibrosis and loss …